1.Efficacy and safety of laparoscopic proximal subtotal gastrectomy and distal gastrectomy in the treatment of gastric cancer
International Journal of Surgery 2024;51(1):37-43
Objective:To explore the efficacy and safety of laparoscopic technology in the treatment of gastric cancer which using proximal subtotal gastrectomy and distal subtotal gastrectomy.Methods:A retrospective analysis was conducted on the clinical data of 98 gastric cancer patients admitted to the Department of General Surgery, General Hospital of Huainan Eastern Hospital Group from January 2016 to January 2020, including 71 males and 27 females with an average age of (62.03±10.6) years old(ranged from 32 to 80 years). All cases were divided into proximal group ( n=28) and distal group ( n=70) according to different surgical methods. The proximal group was treated with laparoscopic proximal subtotal gastrectomy, while the distal group was treated with laparoscopic distal subtotal gastrectomy. SPSS 20.0 software was used to analyze the differences in surgical related clinical indicators, postoperative complications, nutritional status, quality of life, and survival rate between two groups. Kaplan-Merier was used to draw survival curves, and Log-rank test was used to compare the survival differences between the two groups. Results:The number of lymph node dissection in the proximal group was less than that in the distal group, and the difference was statistically significant ( t=2.02, P=0.045). The incidence rate of reflux esophagitis in the proximal group was higher than that in the distal group (57.14% vs 4.29%, χ2=35.75, P<0.001), the incidence rate of reflux gastritis was lower than that of the distal group, the difference was statistically significant(3.57% vs 22.86% P=0.035). The levels of red blood cells, hemoglobin, and albumin in the proximal group were lower than those in the distal group after surgery, and the differences were statistically significant ( t=2.62, P=0.010; t=2.12, P=0.036; t=3.54, P=0.001). One month after surgery, the Karnofsky functional status score in the proximal group was lower than that in the distal group, and the difference was statistically significant ( t=2.27, P=0.025). The postoperative 1, 3, and 5-year survival rates of the proximal group were 85.71%, 64.29%, and 46.43%, respectively, while the postoperative 1, 3, and 5-year survival rates of the distal group were 88.57%, 71.43%, and 57.14%, respectively. There was no statistically significant difference in the survival curves between the two groups ( P>0.05). Conclusions:The incidence rate of reflux esophagitis after laparoscopic proximal subtotal gastrectomy is higher than that of distal subtotal gastrectomy, and the number of lymph nodes cleared during operation is less than that of distal subtotal gastrectomy. Compared with laparoscopic distal subtotal gastrectomy, the nutritional status of patients after proximal subtotal gastrectomy is significantly worse, but there is no significant difference in long-term survival rate between the two groups.
2.Efficacy of Billroth II anastomosis versus Roux-en-Y anastomosis in laparoscopic distal gastrectomy for gastric cancer
Hui CAO ; Yongqiang JIANG ; Luohai LIU ; Tao ZHENG ; Bao JIANG
Chinese Journal of Primary Medicine and Pharmacy 2024;31(9):1363-1367
Objective:To investigate the efficacy of Billroth II anastomosis versus Roux-en-Y anastomosis in laparoscopic distal gastrectomy for gastric cancer. Methods:A case-control study was conducted to retrospectively analyze the clinical data of 110 patients who underwent laparoscopic distal gastrectomy for gastric cancer at the General Hospital of Huainan Oriental Hospital Group from January 2021 to December 2022. According to the different methods of gastrointestinal reconstruction after distal gastrectomy, the patients were divided into an observation group ( n = 61) and a control group ( n = 49). The observation group was treated with Roux-en-Y anastomosis, while the control group received Billroth II anastomosis. The intraoperative blood loss, operation time, postoperative recovery, early postoperative ambulation time, time to first flatus, food intake, length of hospital stay, and complications were compared between the two groups. Results:The operation time in the control group was (140.0 ± 31.5) minutes, which was significantly shorter than that in the observation group [(180.0 ± 30.5) minutes, t = 6.37, P < 0.05]. There were no statistically significant differences in intraoperative blood loss and early postoperative ambulation time between the two groups (both P > 0.05). In the control group, there were 8 cases of alkaline reflux gastritis (16.3%), 3 cases of afferent loop obstruction (6.1%), and 3 cases of dumping syndrome (6.1%). These proportions were significantly higher than those in the observation group, which reported 2 cases of alkaline reflux gastritis (3.3%), 1 case of afferent loop obstruction (1.6%), and 1 case of dumping syndrome (1.6%) (χ2 = 6.15, 4.54, 4.54, all P < 0.05). Conclusion:Using Roux-en-Y anastomosis for gastrointestinal reconstruction in patients undergoing laparoscopic distal gastrectomy for gastric cancer can help prevent against alkaline reflux gastritis, afferent loop obstruction, and dumping syndrome; however, it results in a longer surgical time compared with Billroth II anastomosis.
3.Analysis of the clinical characteristics and related background diseases of 134 type 1 gastric neuroendocrine tumor
Yixuan ZHANG ; Yingying CHEN ; Zhirong QI ; Luohai CHEN ; Jie LUO ; Yuan LIN ; Jixi LIU ; Huangying TAN ; Jie CHEN
Chinese Journal of Digestion 2019;39(8):539-544
Objective To explore the clinical characteristics and related background diseases of type 1 gastric neuroendocrine tumor (g-NET) and to provide reference information for clinical diagnosis and treatment.Methods From Januayy 2011 to February 2019,at the First Affiliated Hospital of Sun Yat-sen University and China-Japan Friendship Hospital,the clinical features and related background diseases of type 1 g-NET patients (41 cases and 93 cases respectively)were retrospectively analyzed.The clinical symptoms,serological indicators,gastroscopic and pathological features,tumor location,metastasis and treatment,and concomitant diseases were statistically described.Results Among 134 patients with type 1 g-NET,there were 53 males (39.6%) and 81 females (60.4 %);and the mean diagnosed age was (51 ± 11) years (21 to 76 years).Main clinical manifestations were non-specific gastrointestinal symptoms.The mean level of serum chromogranin A was (237.7 ± 176.8) μg/L.The endoscopic findings of 97.8% (131/134) of the patients were polypoid or protuberant lesions at gastric fundus or gastric body.And 75.0% (96/128) of the patients had multiple tumors.65.7% (88/134) of the patients had the tumors with the maximum diameter less than 1 cm (77.2%,88/114) and the lesions mainly located in mucosa (59.8%,52/87) and submucosa (40.2%,35/87).The pathological classification of 79.3% (96/121) of the tumors was G1 grade and 20.7% (25/121) were G2 grade.The rate of local lymph node metastasis was 1.4% (1/73) and no distant metastasis was found.About 70.9% (95/134) of the patients received endoscopic treatment.Among the patients,93.6% (103/110) of the patients had chronic atrophic gastritis confirmed by endoscopy or pathology,45.6% (47/103) were confirmed by both endoscopy and pathology.Among the patients with chronic atrophy gastritis,serum gastrin levels of 93.2% (96/103) patients were twice higher than the upper limit of the normal value.The positive rates of antiparietal cells antibody (PCA) and intrinsic factor (IFA) were 78.5% (73/93) and 51.9% (14/27),respectively.The incidence of Helicobacter pylori (H.pylori) infection was 28.1% (16/57).The incidence of autoimmune atrophy gastritis was 80.6% (75/93).The percentage of patients with deficiency of serum vitamin B12 and ferritin was 70.8% (63/89) and 30.7% (27/88),respectively.Patients with anemia accounted for 27.8% (25/90).The patients with microcytic anemia,normocyticanemia and macrocytic anemia were 28.0% (7/25),56.0% (14/25) and 16.0% (4/25),respectively.46.9% (45/96) of the patients had increased thyroid autoantibodies and 17.9% (17/95) patients had changes of thyroid hormone level.Conclusions Type 1 g-NET is more common in women and mainly caused by autoimmune atrophic gastritis.The level of serum PCA and IFA increase in more than half of the patients.And it is often accompanied by vitamin B12 deficiency and autoimmune thyroid disease.

Result Analysis
Print
Save
E-mail